Skip to main content

and
  1. Article

    Open Access

    Molecular characterization of carbapenemase and extended spectrum beta-lactamase producing Acinetobacter baumannii isolates causing surgical site infections in Ethiopia

    Acinetobacter baumannii is an opportunistic pathogen that can cause a variety of nosocomial infections in humans. This study aimed to molecularly characterize extended-spectrum beta-lactamase (ESBL) producing and...

    Seble Worku, Tamrat Abebe, Berhanu Seyoum, Bikila Alemu in BMC Infectious Diseases (2024)

  2. Article

    Open Access

    Bacterial profile of surgical site infection and antimicrobial resistance patterns in Ethiopia: a multicentre prospective cross-sectional study

    Globally, surgical site infections (SSI) are the most commonly reported healthcare-associated infections.

    Seble Worku, Tamrat Abebe, Ashenafi Alemu in Annals of Clinical Microbiology and Antimi… (2023)

  3. Article

    Open Access

    High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers

    COVID-19 pandemic has a devastating impact on the economies and health care system of sub-Saharan Africa. Healthcare workers (HWs), the main actors of the health system, are at higher risk because of their occ...

    Tesfaye Gelanew, Berhanu Seyoum, Andargachew Mulu, Adane Mihret in BMC Infectious Diseases (2022)

  4. Article

    Open Access

    Prevalence of antimicrobial resistance and its clinical implications in Ethiopia: a systematic review

    Antimicrobial resistance is one of the major public health challenges in Ethiopia. However, there is no comprehensive summary of existing AMR data in the country.

    Derbew Fikadu Berhe, Getachew Tesfaye Beyene in Antimicrobial Resistance & Infection Contr… (2021)

  5. Article

    Open Access

    Intensive phase treatment outcome and associated factors among patients treated for multi drug resistant tuberculosis in Ethiopia: a retrospective cohort study

    Multi-drug resistant Tuberculosis (MDR-TB) is a strain of Mycobacterium tuberculosis that is resistant to at least Rifampicin and Isoniazid drugs. The treatment success rate for MDR-TB cases is lower than for dru...

    Teklu Molie, Zelalem Teklemariam, Eveline Klinkenberg in BMC Infectious Diseases (2019)